GENEVA, April 1 -- HLB PHARMACEUTICAL CO., LTD. (27, Gyeonggang-roNamyangju-siGyeonggi-do 12244), 에이치엘비제약 주식회사 (경기도남양주시경강로 27), HLB CELL CO.,LTD (8Fl., Dongtan M tower, 51-9, Dongtancheomdansaneop 1-roHwaseong-siGyeonggi-do 18469), 에이치엘비셀 주식회사 (경기도화성시동탄첨단산업1로 51-9, 동탄엠타워 8층) filed a patent application (PCT/KR2024/014126) for "INJECTABLE COMPOSITION COMPRISING CROSSLINKED HYALURONIC ACID HYDROGEL A...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.